Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,917.00
Bid: 1,919.00
Ask: 1,921.00
Change: -24.00 (-1.24%)
Spread: 2.00 (0.104%)
Open: 1,947.00
High: 1,956.00
Low: 1,907.00
Prev. Close: 1,941.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: Shares Open Firm Even As Hikma And ARM Sink

Wed, 10th Feb 2016 08:34

LONDON (Alliance News) - Stocks in the UK opened mostly higher Wednesday, after three losing sessions, as Hikma Pharmaceuticals and ARM Holdings were the worst performers in the FTSE 100.

Hikma traded down 13% as it said it agreed a lower price for its acquisition of Roxane Laboratories and Boehringer Ingelheim Roxane from German pharmaceutical company Boehringer Ingelheim.

This is as a result of new information having been received from Hikma in relation to the financial performance of Roxane in 2015, following the publication of Hikma's prospectus regarding the acquisition in January.

As a result of this information the two companies have agreed to reduce the purchase price, and Hikma will now pay USD647 million in cash instead of the USD1.18 billion it had originally agreed, although it will still additional issue 40 million shares to Boehringer as part of the consideration at a price of 2,350 pence per share. Hikma shares traded at 1,781.00p.

However, Hikma said that, following further due diligence, it now expects Roxane's revenue for 2015 to come in lower than it had previously anticipated, which it attributed to higher-than-expected rebates.

It now expects Roxane's revenue for 2015 to only be slightly higher than 2014, and for 2016 to be lower than in 2015. As a result, Hikma now expects the acquisition to be slightly dilutive to its adjusted earnings per share in 2016.

Meanwhile, ARM Holdings traded down 5.5% despite reporting a rise in pretax profit in 2015, as it saw a strong performance in its fourth quarter with revenue up 19%.

ARM reported a pretax profit of GBP414.8 million for 2015, up from GBP316.5 million in 2014, as revenue rose to GBP968.3 million from GBP795.2 million, more than offsetting increases in research and development costs. On a dollar basis, as ARM generates a majority of its revenue in dollars, revenue rose to USD1.49 billion from USD1.29 billion.

Looking ahead, ARM said it enters 2016 with a "robust opportunity pipeline", helped by the introduction of new technologies and its expanding market opportunities.

ARM cautioned that whilst economic uncertainty "may influence consumer and enterprise spending, potentially impacting semiconductor revenues and industry confidence", based on current conditions in the semiconductor market, it expects 2016 dollar revenues "broadly in line" with market expectations.

The FTSE 100 index traded up 0.2% at 5,643.88, and the FTSE 250 was up 0.5% at 15,389.37, while the AIM All-Share was down 0.1% at 670.71.

In Europe, the French CAC 40 traded up 0.2% and the German DAX 30 was up 0.4%.

The Nikkei 225 in Tokyo continued its decline after its 5.4% loss on Tuesday. The index ended down 2.3% on Wednesday. The Chinese market remained closed for Lunar New Year, though the Hong Kong market will re-open again on Thursday.

Elsewhere in London, Tullow Oil was one of the worst performers in the FTSE 250, down 2.7%. The oil producer reported a narrower pretax loss in 2015 despite reporting a steep drop in revenue due to the fall in oil prices, as the company said it remains focused on reducing costs and getting the TEN development in Ghana producing.

Tullow had already guided last month that its earnings would be considerably lower year-on-year after lower oil prices hampered results, as a fall in net production from Europe offset a rise from its flagship operations in West Africa.

The oil company, which operates in 22 countries with the majority of its oil production coming from assets in West Africa, reported a USD1.29 billion pretax loss from continuing activities in 2015 compared to a USD2.04 billion loss in 2014.

That result came despite a steep drop in revenue to USD1.60 billion from USD2.21 billion, yielding a gross profit of USD591.3 million compared to USD1.09 billion last year - in line with Tullow's guidance last month.

Sophos Group continued as the worst performer in the FTSE 250, down 9.9%, after falling 15% on Tuesday, even though the security software and hardware developer reported a rise in billings in the third quarter of its financial year as revenue also rose.

In the economic calendar for Wednesday, UK industrial and manufacturing data are at 0930 GMT, just before the European Commission's economic growth forecasts at 1000 GMT. At 1200 GMT are US mortgage applications. The National Institute of Economic and Social Research UK GDP forecast is at 1500 GMT and the US Energy Information Administration's crude oil stock at 1530 GMT.

Markets will particularly be looking ahead to Federal Reserve Chair Janet Yellen's testimony to the Committee on Financial Services in the US House of Representatives at 1500 GMT.

By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
12 Apr 2023 07:52

LONDON BRIEFING: Anglo American's De Beers shines; Unite bookings up

(Alliance News) - Stocks in London were called flat on Wednesday, with the focus for the day on a US inflation reading in the afternoon, before the release of central bank meeting minutes later.

Read more
12 Apr 2023 07:18

Hikma appoints Riad Mishlawi as CEO

(Sharecast News) - Hikma Pharmaceuticals said Riad Mishlawi, president of the group's injectables business, has been appointed chief executive Officer, effective from September 1.

Read more
6 Apr 2023 09:20

LONDON BROKER RATINGS: Goldman raises Spirent to 'neutral' from 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
16 Mar 2023 15:50

UK dividends calendar - next 7 days

Friday 17 March 
JPMorgan Claverhouse Investment Trust PLCdividend payment date
Knights Group Holdings PLCdividend payment date
NCC Group PLCdividend payment date
Pershing Square Holdings Ltddividend payment date
Ruffer Investment Co Ltddividend payment date
Witan Investment Trust PLCdividend payment date
Monday 20 March 
Aquila Energy Efficiency Trust PLCdividend payment date
Essentra PLCspecial ex-dividend payment date  
Shaftesbury Capital PLCdividend payment date
Tuesday 21 March 
abrdn Asia Focus PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
Unilever PLCdividend payment date
Wednesday 22 March 
abrdn Equity Income Trust PLCdividend payment date
Thursday 23 March 
BlackRock Energy & Resources Income Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
Close Brothers Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Craneware PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Glanbia PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Hipgnosis Songs Fund Ltdex-dividend payment date
Jersey Electricity PLCdividend payment date
Nichols PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Prudential PLCex-dividend payment date
Schroders PLCex-dividend payment date
Securities Trust of Scotland PLCex-dividend payment date
Volution Group PLCex-dividend payment date
XP Power Ltdex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
13 Mar 2023 09:40

LONDON BROKER RATINGS: JPMorgan cuts BAT; raises Bunzl

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
9 Mar 2023 09:15

LONDON BROKER RATINGS: Liberum cuts National Express to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.